Biopharma News

Jun 25, 2018
By BioPharm International Editors
GW Research’s Epidiolex, which treats two forms of epilepsy, receives FDA’s approval; spurs FDA reminders about unapproved products.
Jun 22, 2018
By BioPharm International Editors
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Roche’s personalized healthcare strategy.
Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.
Jun 20, 2018
By BioPharm International Editors
The company has resubmitted a biologics license application to FDA for its proposed biosimilar to Roche’s Herceptin.
Jun 13, 2018
By BioPharm International Editors
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
Jun 13, 2018
By BioPharm International Editors
WuXi Biologics will invest $60 million to establish a biologics production facility in Massachusetts.
Jun 13, 2018
By BioPharm International Editors
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
Jun 13, 2018
By BioPharm International Editors
Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.
Jun 07, 2018
By BioPharm International Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
native1_300x100
lorem ipsum